Correlation Between Gossamer Bio and Recursion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Gossamer Bio and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gossamer Bio and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gossamer Bio and Recursion Pharmaceuticals, you can compare the effects of market volatilities on Gossamer Bio and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gossamer Bio with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gossamer Bio and Recursion Pharmaceuticals.
Diversification Opportunities for Gossamer Bio and Recursion Pharmaceuticals
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Gossamer and Recursion is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Gossamer Bio and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and Gossamer Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gossamer Bio are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of Gossamer Bio i.e., Gossamer Bio and Recursion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Gossamer Bio and Recursion Pharmaceuticals
Given the investment horizon of 90 days Gossamer Bio is expected to under-perform the Recursion Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Gossamer Bio is 1.26 times less risky than Recursion Pharmaceuticals. The stock trades about -0.02 of its potential returns per unit of risk. The Recursion Pharmaceuticals is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 717.00 in Recursion Pharmaceuticals on September 26, 2024 and sell it today you would earn a total of 7.00 from holding Recursion Pharmaceuticals or generate 0.98% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gossamer Bio vs. Recursion Pharmaceuticals
Performance |
| Timeline |
| Gossamer Bio |
| Recursion Pharmaceuticals |
Gossamer Bio and Recursion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gossamer Bio and Recursion Pharmaceuticals
The main advantage of trading using opposite Gossamer Bio and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gossamer Bio position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.| Gossamer Bio vs. Fate Therapeutics | Gossamer Bio vs. Caribou Biosciences | Gossamer Bio vs. Karyopharm Therapeutics | Gossamer Bio vs. Hookipa Pharma |
| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |